Tenax Therapeutics (TENX) Receivables (2016 - 2017)
Historic Receivables for Tenax Therapeutics (TENX) over the last 7 years, with Q3 2017 value amounting to $24649.0.
- Tenax Therapeutics' Receivables fell 6604.82% to $24649.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $24649.0, marking a year-over-year decrease of 6604.82%. This contributed to the annual value of $72599.0 for FY2016, which is N/A changed from last year.
- As of Q3 2017, Tenax Therapeutics' Receivables stood at $24649.0, which was down 6604.82% from $24649.0 recorded in Q2 2017.
- Tenax Therapeutics' 5-year Receivables high stood at $541463.0 for Q2 2013, and its period low was $24648.0 during Q2 2016.
- Moreover, its 5-year median value for Receivables was $66108.0 (2014), whereas its average is $93660.3.
- Per our database at Business Quant, Tenax Therapeutics' Receivables surged by 100423.78% in 2013 and then tumbled by 8779.09% in 2014.
- Quarter analysis of 5 years shows Tenax Therapeutics' Receivables stood at $123873.0 in 2013, then plummeted by 70.65% to $36358.0 in 2014, then surged by 36.0% to $49448.0 in 2015, then skyrocketed by 46.82% to $72599.0 in 2016, then plummeted by 66.05% to $24649.0 in 2017.
- Its Receivables stands at $24649.0 for Q3 2017, versus $24649.0 for Q2 2017 and $24649.0 for Q1 2017.